Background Replication initiator 1 (Repin1) is a zinc finger protein highly expressed in liver and adipose tissue. The Repin1 resides within a quantitative trait locus (QTL) for body weight and triglyceride levels in the rat, and its hepatic deletion in mice results in improved insulin sensitivity and lower body weight. Here, we analyzed whether genetic variation within the Repin1 affects parameters of glucose and lipid metabolism. Methods We sequenced REPIN1 in 48 non-related Caucasian subjects. We discovered a 12 base pair deletion (12 bp del; rs3832490), which was subsequently genotyped in two well-characterized cohorts (N = 3013) to test for associations with metabolic traits. Functional consequences of the variant were investigated in HepG2 cells in vitro.
Introduction
It is well acknowledged that obesity and related traits are influenced by genetic factors. Despite recent advances in high throughput technologies which led to the identification of numerous genetic variants associated with complex metabolic traits including obesity [1] , the genetic architecture of these phenotypes is far from being fully understood. In particular, identification of target genes within the loci associated with phenotypes of interest and understanding their functional consequences remains a challenging task. The replication initiator 1 (Repin1) residing on rat chromosome 4 within a quantitative trait locus (QTL) for body weight, serum fasting insulin, and triglycerides does represent such a gene [2, 3] . A single nucleotide polymorphism (SNP) in the coding region and a triplet repeat (TTT) in the 3′-untranslated region (UTR) in the Repin1 have been shown to be associated with altered metabolism in rat strains [3] , thus rendering Repin1 a plausible candidate for the respective QTL.
Repin1 is a replication initiation-region protein 60 kDa (RIP60) firstly described in a study investigating DNAbinding proteins involved in replication activation of the Chinese hamster dihydrofolate reductase gene (dhfr) [4] . Moreover, Repin1 is a polydactyl zinc finger protein containing 15 zinc finger (ZF) DNA-binding motifs, and these are organized in three zinc finger hand clusters, cluster Z1 includes ZFs 1-5, cluster Z2 includes ZFs 6-8, and cluster Z3 includes ZFs 9-15 [5] . The clusters have different affinities to bind DNA [5] . Repin1 is ubiquitously expressed with the highest levels in adipose tissue and liver [3] . In humans, REPIN1 comprises four exons and maps on These authors contributed equally: Jacqueline Krüger, Claudia Berger. chromosome 7q36.1. Recent studies suggest that Repin1 plays a role in the adipocyte biology. In 3T3-L1 cells, a Repin1 knockdown resulted in smaller lipid droplets and lower palmitate uptake, as well as improved glucose transport [6] . Furthermore, a whole-body Repin1 deletion in db/db and BL/6N mice improved insulin sensitivity and chronic hyperglycemia, most likely due to reduced fat mass and lower adipose tissue inflammation [7, 8] . Both liverand adipose tissue-specific Repin1 knockout mice (LRep1 −/− ) exhibit improved whole-body insulin sensitivity, accompanied with significantly lower triglyceride content in the liver and secondary changes in adipose tissue [8, 9] . Altogether, these data point to a crucial role of Repin1 in lipid and glucose metabolism in mice. Since a balance between storage and release of lipids by adipose tissue is essential for maintenance of normal energy homeostasis [10] , Repin1 might also be considered as a factor contributing to ectopic lipid accumulation in peripheral tissues, such as liver, pancreas, or skeletal muscle under conditions of energy surplus.
Here, we tested for the first time the hypothesis that genetic variants within the REPIN1 are associated with alterations in glucose and lipid metabolism. We sequenced the REPIN1 in 48 non-related Caucasian subjects and identified a 12 base pair deletion, which was subsequently genotyped in two well-characterized cohorts (N = 3013). Functional consequences of this variant were investigated in HepG2 cells in vitro.
Material and methods

Subjects
Informed consent was given by all the participants and the study was approved by the Ethics Committee at the University of Leipzig.
Leipzig cohort
The Leipzig cohort was recruited at the University Hospital of Leipzig, Germany, and includes 1982 subjects (1098 women and 884 men); 578 subjects had normal glucose tolerance (NGT, BMI 26.6 ± 5.9 kg/m 2 ), 176 subjects had an impaired glucose tolerance (IGT, BMI = 30.5 ± 5.9 kg/m 2 ), and 1093 subjects had type 2 diabetes (T2D, BMI 30.4 ± 6.1 kg/m 2 ) according to the American Diabetes Association (ADA) criteria from 2010 [11] . The remaining subjects had type 1 diabetes or latent autoimmune diabetes of adults (LADA) and were excluded from further analysis. About 557 individuals were lean (BMI 23.1 ± 1.6 kg/m 2 ), 736 were overweight (BMI 27.3 ± 1.4 kg/m 2 ), and 689 subjects had obesity (BMI 35.4 ± 5.9 kg/m 2 ). Anthropometric and metabolic measurements included BMI, % body fat, waist to hip ratio (WHR), glucose, insulin, cholesterol, triglycerides, and free fatty acids serum concentrations. In addition, the participants without prior T2D diagnosis underwent an oral glucose tolerant test (oGTT). The main characteristics of the cohort are given in Table 1 . For a small subgroup (N = 20), subcutaneous and visceral adipose tissue were removed and adipocytes were isolated by collagenase (1 mg/ml) digestion. To investigate cell size and adipocyte number, aliquots of adipocytes were fixed with osmic acid and counted in a Coulter counter as previously described [12] .
Sorbs cohort
The self-contained population of Sorbs in Germany had undergone extensive phenotyping as recently described elsewhere [13] [14] [15] . Briefly, it included standardized questionnaires to assess past medical history, family history, and collection of anthropometric data. The cohort includes 614 women and 417 men, had a mean age of 48 ± 16 years, and mean BMI 26.9 ± 4.9 kg/m 2 . Among the 1031 subjects, 397 were lean (BMI 22.4 ± 1.7 kg/m 2 ), 400 were overweight (BMI 27.4 ± 1.4 kg/m 2 ), and 234 subjects had obesity (BMI 33.9 ± 3.8 kg/m 2 ). Anthropometric parameters (body weight, BMI, % body fat, WHR) and metabolic parameters (lipids, oGTT, HOMA IR) were available for analyses. The main characteristics of the cohort are given in Table S1 .
In both cohorts, blood samples were deep-frozen and stored at −80°C. Glucose was assessed by the Hexokinase method (Automated Analyzer Modular, Roche Diagnostics, Mannheim, Germany) and serum insulin was measured using the AutoDELFIA Insulin assay (PerkinElmer Life and Analytical Sciences, Turku, Finland). Total serum cholesterol and TG concentrations were measured by standard enzymatic methods (CHOD-PAP and GPO-PAP; Roche Diagnostics). Serum LDLcholesterol and HDL-cholesterol concentrations were determined using commercial homogeneous direct measurement methods (Roche Diagnostics). All assays were performed in an automated clinical chemistry analyzer (Hitachi/ Roche Diagnostics) at the Institute of Laboratory Medicine, University Hospital Leipzig.
Sequencing
The REPIN1 (four exons, exon-intron boundaries, 5′ and 3′ UTRs based on NCBI reference NM_013400.3) was sequenced in 48 non-related Caucasian subjects (27 subject with T2D and 21 controls, 23 women and 25 men). Sequencing was performed using the Big Dye ® Terminator (Applied Biosystems, Inc., Foster City, CA) on an 
Genotyping of SNPs
SNPs were genotyped in both study cohorts by employing the TaqMan SNP Genotyping assay system according to the manufacturer's protocol and by using the ABI PRISM ® 7500 Sequence Detecting System (Applied Biosystems, Inc., Foster City, CA). To limit genotyping errors, a random 5% selection of samples was re-genotyped; all genotypes matched initially designated genotypes.
Genotyping of the 12 bp deletion variant in humans
Sequencing revealed a 12 bp del (CCGCCAGGGGCC/−) in exon 4 of REPIN1 ( Figure S1 ). Screening for the deletion in both study cohorts was done by restriction fragment length polymorphism (RFLP). DNA was amplified by PCR and the corresponding product (564 bp) was subsequently digested with the enzyme ApaI. The experimental protocol including PCR conditions and primer sequences is provided in Supplemental Table S3 . Briefly, the digestion with ApaI resulted in 3 fragments (99 bp, 143 bp, 322 bp) in wildtype homozygous subjects, two fragments (230 bp and 322 bp) in homozygous carriers of the deletion, and four fragments (99 bp, 143 bp, 230 bp, 322 bp) in heterozygous subjects. The products were visualized using gel electrophoresis ( Figure S2 ).
Cloning and expression of recombinant REPIN1 wildtype and 12 bp deletion variants REPIN1 constructs, which consist of the coding sequence of exon 4 with (deletion) or without 12 bp del (wildtype) and a size of 1.7 kb, were cloned into the pNTAP-β-vector (InterPlay Mammalian TAP System, Agilent Technologies, Waldbronn, Germany). Subsequently, hepatocellular carcinoma cells (HepG2) were transfected with the eukaryotic expression vectors for the REPIN1 wildtype and deletion or with the empty vector. For transfection of HepG2, cells GeneJammer Transfection Reagent (Agilent Technologies, Waldbronn, Germany) was used. Cells were grown until 80% confluence in a 6-well plate with growth medium (RPMI-1640 medium (Biochrom GmbH, Berlin, Germany), supplemented with 10% fetal bovine serum (FBS, AppliChem, Darmstadt, Germany), 100 units/ml of penicillin (Biochrom GmbH, Berlin, Germany) and 100 mg/ ml of streptomycin (Biochrom GmbH, Berlin, Germany)). Three microliters of transfection reagent was mixed with 97 µl of serum-free and antibiotic-free RPIM 1640 medium and incubated for 5 min. Afterwards 1 µg of wt or 12 bp del variant plasmid was added to the transfection solution and incubated for 45 min at room temperature in two different approaches. The different plasmids contained the wt variant of the 4th exon of REPIN1 or the 4th exon with the deletion of 12 bp.
The transfection mixture was added dropwise to one well of the 6-well plate. In addition, three negative controls were conducted: a cell control, a reagent control, and a DNA control. Twenty-four hours after transfection, the medium was changed to selection medium (growth medium supplemented with 50 mg/ml Geneticin (AppliChem, Darmstadt, Germany)). The medium was replaced twice a week until the control cells died. The successful transfection was verified by growth with selection media containing Geneticin and by PCR with a REPIN1 specific primer pair (fw: AGATTCACAAGCGATCCGAG, rw: ACTTCTGGCT-GAAGGCT TTG) and restriction digestion with ApaI. After amplification and digestion, the reactions were visualized using Gelred (GeneOn GmbH, Ludwigshafen, Germany) staining in 1% agarose gels. For the cells carrying the REPIN1 plasmid with the 12 bp del, only two fragments were detected (Fig. 1a) . The overexpression was confirmed by qPCR (Lightcycler) using a specific REPIN1 probe and calculated relative to 18S rRNA (both Applied Biosystems, Hs00274221_s1, Hs99999901_s1, Warrington, GB) (Fig. 1b) .
Cell culture and in vitro assays
HepG2 cell line was purchased from American Type Culture Collection (Manassas, VA, USA). The cells were cultured at 37°C in humidified air with 5% CO 2 in RPMI-1640 medium (Biochrom GmbH, Berlin, Germany), supplemented with 10% FBS (AppliChem, Darmstadt, Germany), 100 units/ml of penicillin (Biochrom GmbH, Berlin, Germany), 100 mg/ml of streptomycin (Biochrom GmbH, Berlin, Germany), and 50 mg/ml Geneticin (AppliChem, Darmstadt, Germany).
Measurement of glycerol, triglyceride, and retinolbinding protein (RBP4) concentrations
Glycerol concentration was measured by using the Adipolysis Assay Kit (Merck/Millipore, Darmstadt, Germany). Cells were cultivated in 6-well plates to reach 80% confluence and afterwards harvested, washed, and lysed in sucrose buffer. Free Glycerol Assay Reagent was added to samples, standard, and blank and absorption was detected at 560 nm. Glycerol concentration was calculated with the provided standard curve. The protein level of the cells was taken as reference.
Triglyceride concentration in cells was determined using the LabAssay TM Triglyceride (GPO-DAOS method)-Kit (Wako Chemicals, Neuss, Germany). Cells were harvested, washed, lysed in sucrose buffer, mixed with color reagent, and measured at 620 nm. The protein level of the cells was taken as reference.
RBP4 concentration was measured by RBP4 (human) Competitive ELISA Kit (Adipogen, Seoul, South Korea). Cells were grown in a 6-well plate and the medium was taken after 48 h incubation. ELISA was performed with the medium according to the manufacturer's protocol.
Lipid staining
HepG2 cells were grown in 24-well plates for 24 h, washed and incubated with 30 μl/ml AdipoRed TM (Lonza, Basel, CH) in phosphate buffered saline (PBS) (wo Ca 2+ /wo Mg 2+ pH 7.4). Nuclei were counterstained with Hoechst (1 μg/ml in MilliQ water) to normalize the AdipoRed signal. To quantify the lipid staining, the fluorescence was measured at the FLUOstar OPTIMA (BMG LABTECH) and the amount of AdipoRed/Hoechst was analyzed.
RNA isolation and reverse transcriptase PCR (RT-PCR) analysis
Total RNA from the cultured cells was isolated using QIAzol reagent (Qiagen, Hilden, D) according to the manufacturer's instructions. cDNA was synthesized from 2 µg of total RNA, using Superscript II Reverse Transcriptase (Invitrogen, Darmstadt, Germany). RT-generated cDNAs were amplified and measured by qPCR using Lightcycler (Roche, Germany) with selective primers (Supplemental Table S4 ), purchased from Biomers (Ulm, Germany). Specific mRNA expression was calculated relative to 18S rRNA which was used as reference due to its resistance to glucose-dependent regulation [16] . mRNA expression was quantified by using the second derivative maximum method. 
FACS analysis
Statistical analysis
Prior to the analyses, all non-normally distributed parameters were logarithmically transformed to approximate a normal distribution. To test the 12 bp del for genetic association with metabolic traits, linear regression models adjusted for covariates were used. Logistic regression analyses were done for case control studies for T2D (NGT vs. T2D) and obesity (lean vs. obese). For these analyses, two models of inheritance were considered. In the additive model, homozygotes for the major allele, heterozygotes and homozygotes for the minor allele (12 bp del) were coded to a continuous numeric variable for genotype (as 0, 1, 2). A dominant model for the minor allele was defined as contrasting genotypic groups including homozygotes for the minor alleles and heterozygotes vs. subjects homozygous for the major allele. The analysis of associations of the variants with quantitative traits was done under linear 
18S rRNA. *p < 0.05, **p < 0.01, ***p < 0.005 regression in non-diabetic subjects to avoid diabetes status or treatment interfering with potential effects of the variants on these parameters. For the in vitro analyses, data are given as means ± standard error of the mean (SEM). Data sets were analyzed for statistical significance using a two-tailed unpaired t-test.
p-Values ≤0.05 were considered to provide nominal evidence for association and are provided without correction for multiple testing. Statistical analyses were performed using SPSS statistics version 20.0.1 (SPSS, Inc., Chicago, IL, USA) and GraphPad Prism 6.05 (GraphPad Software, La Jolla, USA).
Results
Sequencing of REPIN1
Sequencing of the REPIN1 revealed 12 variants within the coding region, which fell into 9 linkage disequilibrium groups (L.D.) All SNPs were in Hardy Weinberg equilibrium. One of the variants, the 12 bp deletion (rs3832490) resides in exon 4 and predicts a protein sequence lacking four amino acids (PPGA) at position P356_A359del without causing a frame shift (see Figure S1 ).
Three of 48 sequenced subjects were heterozygote carriers of the 12 bp del, which was further confirmed by genotyping via RFLP.
The 12 bp del as well as eight polymorphisms (rs3735170, rs10278590, rs10229175, rs9640161, rs4725336, rs17173703, rs1051760, rs6971465; Figure S3 ) representing the remaining L.D. groups were genotyped for association analyses.
Association studies
Association analyses of the 12 bp deletion (rs3832490) with T2D and obesity
In the Sorbs cohort, rs3832490 was associated with T2D. The frequency of carriers of the 12 bp del (homozygous and heterozygous) was significantly higher in subjects with NGT compared with patients with T2D (p < 0.05 after adjusting for age, sex, and BMI in a dominant model of inheritance for the minor allele; Table 1 ). Albeit not significant, the genotype distribution in subjects with NGT and with T2D was similar in the Leipzig cohort (Supplementary  table S5 ). Finally, a combined analysis including both cohorts rendered a significant association with T2D (p = 5.89 × 10 −3 ; after adjusting for age, sex, and BMI) ( Table 2) . In a case control study for obesity, comparing lean (BMI < 25 kg/m 2 ) with obese (BMI > 30 kg/m 2 ) subjects, no association was observed in both cohorts (Table 1, Supplemental Table S5 ). 
Association of the 12 bp deletion (rs3832490) with metabolic traits
There were no significant associations of the 12 bp deletion (rs3832490) with any of the studied metabolic traits, most likely due to the weak statistical power, given the low frequency of the variant. It is noteworthy, however, that the three Sorbs homozygous for the deletion had lower fasting plasma glucose, HOMA B as well as HOMA IR, when compared with the non-carriers of the variant. The three subjects had also a lower BMI, WHR, and % body fat (Table 2) . Interestingly, the same subjects had higher mean HDL cholesterol and lower serum triglycerides, but on the other hand they manifested higher LDL cholesterol as well as higher total cholesterol. No homozygous carriers of the REPIN1 deletion variant were found in the Leipzig cohort. The analyses showed an association of the variant with percentage body fat, with heterozygous carriers having less body fat and smaller maximum of adipocyte size in subcutaneous and visceral adipose tissue (all p < 0.05 after adjusting for age and sex; Table 3 ). But there is also a strong and significant correlation between the body fat and the adipocyte size in the Leipzig cohort with r = 0.728 (6.1 × 10 −4 ) and r = 0.540
) in visceral and subcutaneous adipose tissue, respectively.
Association of genetic variation in REPIN1 with metabolic traits
In addition to the 12 bp del (rs3832490), we genotyped eight SNPs representing major linkage disequilibrium groups within the REPIN1. In the Leipzig cohort, four of the eight tested SNPs (rs1051760, rs6971465, rs10278590, and rs17173703, Supplemental Table S6 ) showed nominal association with glucose infusion rate (GIR) during hyperinsulinemic-euglycemic clamp (p < 0.05 adjusted for age, sex, and BMI). In addition, rs1051760, rs3735170, and rs17173703 exhibited an association with HbA1c (Supplemental Table S6 ). Moreover, rs17173703 was associated with total and LDL cholesterol, whereas rs9640161 and rs10229175 showed associations with serum triglycerides Table S6 ). No significant associations were found in the Sorbs cohort for any variant (Supplemental Table S7 ).
Functional analysis of the 12 bp deletion in REPIN1 in HepG2 cells
Cloning and expression of the recombinant REPIN1 wildtype and 12 bp del variant Figure 1a shows the result of the gel electrophoresis after PCR and ApaI digestion with the two bands for the deletion and three bands for the wildtype REPIN1 overexpressing cells. mRNA expression of REPIN1 was 190% higher in wildtype and 230% higher in cells expressing the variant with deletion than in untransfected cells or the vector control. However, there was no significant difference between the del and wt variant (p = 0.40). Consistently, the protein levels were comparable between the wt and 12 bp del variant as well (data not shown).
No difference between untransfected and vector control was found (Fig. 1b) .
Lipid staining and cell differentiation
Given the previously reported role of Repin1 in regulation of key genes of glucose and lipid metabolism [9] , we investigated the effects of the 12 bp del on intracellular lipid content, as well as expression of fatty acid and glucose transporter genes. The intracellular lipid droplets can be assessed by the lipophilic AdipoRed assay. As indicated by these assays, HepG2 cells transfected with the REPIN1 12 bp del variant (Fig. 2a) seemed to have more stained lipid droplets than the cells transfected with the wildtype variant (Fig. 2b) . Consistently, after quantification using AdipoRed and Hoechst, cells carrying the 12 bp del had significantly Furthermore, cells with the REPIN1 12 bp del variant had a higher expression of REPIN1 target transcription factors such a peroxisome proliferator activated receptor α (PPARA; 50% higher than wildtype REPIN1 cells), PPARG-Isoform 2 (59%), and sterol regulatory elementbinding protein 1c (SREBP-1c; 30%), suggesting that these cells exhibited stronger lipid accumulation than wildtype transfected cells. No gene variant-related difference was seen for PPARG isoform 1 (Fig. 2d) .
Fatty acid and glucose transporter genes
The 12 bp del resulted in a significantly higher mRNA expression of fatty acid transport protein 4 (FATP4; 20%) and CD36 (88%), whereas apolipoprotein M (APOM -33%) was significantly downregulated in cells transfected with the deletion variant (Fig. 2e) . No differences were found for FATP2 and FATP5.
Glycerol levels in HepG2 cells with the 12 bp del were twice as high as in the wildtype form (Fig. 2f) .
Furthermore, the 12 bp del resulted in a higher expression of glucose transporter protein 2 (GLUT2; 48% above the control) (Fig. 3a) . Consistently, the percentage of GLUT2-positive cells was significantly higher in cells with the REPIN1 12 bp del variant in comparison to the REPIN1 wildtype variant (Fig. 3b) .
Finally, mRNA expression of retinol binding protein 1 (RBP1) was 48% lower in wildtype overexpressing cells compared to cells expressing the REPIN1 12 bp del (Fig. 3c) . In contrast, the expression of RBP4 and transthyretin (TTR) (Fig. 3c ) was significantly higher in these cells (by 26% and 32%, respectively). In line with this, ELISA measurements showed 16% higher circulating RBP4 levels in media of cells with the 12 bp del (Fig. 3d) .
Discussion
Repin1 is a zinc finger protein highly expressed in liver and adipose tissue [3] . The Repin1 resides within a QTL for body weight and triglyceride levels in the rat [2] , and its hepatic deletion in mice results in improved insulin sensitivity and lower body weight [9] , most likely to be explained by its influence on genes of the fatty acid and glucose metabolism in adipocytes [6] . Here, we analyzed the consequences of human genetic variation within REPIN1 on glucose and lipid metabolism.
Sequencing of the coding region of REPIN1 revealed nine representative genetic variants including a 12 bp del (rs3832490). Our data show that common genetic variation in REPIN1 moderately associates with traits related to glucose and lipid metabolism, such as insulin sensitivity measured by hyperinsulinemic-euglycemic clamps, HbA1c, total and LDL cholesterol, as well as serum triglycerides. One of the most promising functional variants found by sequencing, the 12 bp deletion (rs3832490) is a rare variant with minor allele frequency (MAF) 0.062, which significantly constrained the statistical power of association analyses with metabolic traits. In both study cohorts including 1402 subjects with NGT, we only found three subjects homozygous for the deletion variant. They tend to have lower serum glucose and insulin levels, as well as HOMA IR, suggesting that the deletion might be associated with improved insulin sensitivity, which ultimately results in a reduced risk of T2D. It is noteworthy that the carriers of the deletion also show lower BMI, WHR, and less body fat, as well as smaller adipocytes, which could, at least partially, mediate the observed beneficial effects on glucose metabolism. Despite the lack of statistical power, these data are congruent with the findings from animal studies demonstrating that liver-restricted Repin1 deficiency improves whole-body insulin sensitivity, alters lipid metabolism, and causes secondary changes in adipose tissue in the LRep1 (−/−) mice [6] . Moreover, mRNA as well as protein expression of GLUT2, representing the main transporter (independent of insulin stimulation) in hepatocytes [17] , was significantly increased in vitro in cells expressing REPIN1 with the 12 bp del. In line with this, the cells with REPIN1 12 bp del have a tendency for higher basal glucose uptake, which is independent from insulin stimulation (data not shown). Consistently, Kern et al. showed a higher Glut2 expression in a Repin1 knockout mouse model [9] , which further implies that the observed associations of the 12 bp del with improved metabolic phenotypes might be attributed to Repin1 effects on Glut2 regulation.
Whereas the Repin1 deletion seems to be associated with improved glucose metabolism, carriers of the 12 bp del variant tend to have a higher total cholesterol and LDL cholesterol, but lower serum triglycerides. Our in vitro studies further show that the 12 bp del induces higher expression of the fatty acid transporter CD36 and higher circulating glycerol levels. The higher expression of CD36 in the cells with the 12 bp del in REPIN1 most likely reflects higher REPIN1 expression, because Repin1 knockout mice have lower Cd36 expression [9] , and Miquilena-Colina et al. suggested a link between higher expression of CD36 (mRNA and protein) and decreased insulin sensitivity [18] . FATP4 is a membrane protein of the endoplasmatic reticulum metabolizing fatty acids [19] . Higher expression of FATP4 caused by the 12 bp del might indicate an increased rate of metabolism associated with a decrease in fatty acid concentration in the cell.
In contrast, we show that PPARα, controlling β-oxidation in liver, skeletal muscle, and heart [20] , was overexpressed in cells transfected with the REPIN1 12 bp deletion. Increased expression of SREBP-1C in these cells further suggests a role of REPIN1 in regulating genes of lipogenesis, as well as adipogenesis through SREBP-1C and PPARγ [21] [22] [23] . Further investigations are warranted to clarify whether the effects on mRNA expression of fatty acid transporters and transcription factors might ultimately explain the higher cell glycerol content elicited by the 12 bp del.
Interestingly, overexpression of REPIN1 with the 12 bp del decreased the expression of apolipoprotein M (APOM), a reverse transport protein of cholesterol [24] . Since APOM has been shown to be negatively associated with total cholesterol [25] , one might expect higher cholesterol levels in subjects carrying the REPIN1 deletion. In line with this, we observed increased cholesterol in subjects homozygous for the 12 bp del. Nevertheless, studies with larger human cohorts will be inevitable to test whether the REPIN1 deletion effects on APOM would translate into higher cholesterol levels in individuals carrying the deletion.
Finally, whereas, both in vivo and in vitro data seem to be consistent with regard to glucose metabolism, they are inconclusive regarding lipid metabolism and obesity. These data were achieved in in vitro experiments using only one cell culture system that, due to the substantially lower molecular complexity, cannot entirely resemble the in vivo situation. Also of note, well-acknowledged differences in the physiology between species (mice vs. humans) have to be taken into account. Therefore, we interpret these findings with caution and acknowledge that further functional studies using different cell types are warranted to elucidate the precise molecular mechanisms by which genetic variation in REPIN 1 affects obesity-related traits. Although such studies will undoubtedly shed more light on molecular mechanisms whereby the 12 bp del propagates its metabolic effects, the GTEx Portal [26] (https://www.gtexportal.org) does report rs3832490 as an eQTL in skeletal muscle and other variants (rs1051760, rs3735170, rs6971465, rs9640161) as eQTLs in sc and/or vis adipose tissue. These data implicate a possible regulatory role of the 12 bp deletion in gene transcription. Accordingly, the Regulome database [27] (www.regulomedb.org/) indicated minimal evidence for binding, binding of RNA polymerase II subunit and enhancer for chromatin modification, which however, has not been reported for liver or adipose tissue.
In conclusion, our data suggest that genetic variation in REPIN1 may contribute to changes in parameters of glucose and lipid metabolism, most likely due to specific and Repin1 genotype-related regulation of target gene expression in glucose metabolism, insulin sensitivity, fatty acid transport, and adipogenesis.
